文献速递急性肾损伤血液净化与透析

低剂量急性腹膜透析与间歇性血液透析治疗急性肾损伤的随机对照试验

Lower-Dosage Acute Peritoneal Dialysis versus Acute Intermittent Hemodialysis in Acute Kidney Injury: A Randomized Controlled Trial.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-05-29

这项多中心随机对照试验比较低剂量急性腹膜透析(18–24 L/天)与间歇性血液透析(每周三次)在急性肾损伤患者中的效果,主要终点为28天死亡率。结果显示两组28天死亡率无显著差异(50% vs 49%),低剂量腹膜透析未显示非劣效性,但两组透析无生存率及7天液体平衡无显著差异。

要点

  • 低剂量腹膜透析与间歇性血液透析28天死亡率无显著差异。
  • 腹膜透析组每周Kt/V尿素较低(2.11 vs 2.55)。
  • 血液透析组透析中低血压更常见,腹膜透析组低钾血症更常见。

核心结论

  • 在急性肾损伤患者中,低剂量急性腹膜透析与间歇性血液透析的28天死亡率无显著差异。

研究设计与样本

  • 多中心随机对照试验,纳入157例急性肾损伤患者,80例分配至腹膜透析组,77例分配至间歇性血液透析组。

主要发现

  • 28天死亡率腹膜透析组50%,间歇性血液透析组49%,风险差0.6(95%CI −15.0至16.3)。
  • 28天透析无生存率腹膜透析组42%,间歇性血液透析组37%,风险差4.6(95%CI −11.1至20.3)。
  • 每周Kt/V尿素腹膜透析组2.11±1.14,间歇性血液透析组2.55±1.11。
  • 7天液体平衡两组无显著差异。
  • 间歇性血液透析组透析中低血压更常见,腹膜透析组低钾血症更常见。

关键数值与推荐

  • 非劣效性界值:28天死亡率风险差(腹膜透析-血液透析)的95%CI上限<20%。
  • 急性腹膜透析剂量为每天18–24 L,间歇性血液透析为每周三次。

临床怎么用

  • 低剂量急性腹膜透析可作为急性肾损伤的替代肾脏替代治疗方式,但需注意低钾血症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: The efficacy of acute peritoneal dialysis is still controversial. There was no significant difference in 28-day mortality between acute peritoneal dialysis and intermittent hemodialysis. BACKGROUND: Lower delivered dose of acute peritoneal dialysis (PD) in AKI requires less resources but raises concerns regarding adequate solute and water clearance. The relative merits of lower-dose PD versus intermittent hemodialysis remain uncertain. METHODS: A multicenter randomized controlled trial compared the outcomes between acute lower-dosage PD (18–24 L per day) and intermittent hemodialysis (three times per week) from May 2018 to January 2021 in patients with AKI. The primary outcome was 28-day mortality rate. Secondary outcomes included 28-day dialysis-free survival and kidney recovery, metabolic profile, and procedure-related complications. Noninferiority of PD to hemodialysis would be demonstrated if the upper bound of the 95% confidence interval ( CI) on risk difference (PD-hemodialysis) in 28-day mortality rates between the two groups was <20%. RESULTS: We included 157 patients (80 allocated to PD and 77 to intermittent hemodialysis). Before KRT initiation, baseline clinical characteristics between groups were comparable. The overall mean age was 57±15 years. The most frequent cause of AKI was sepsis (68%). There was no difference in 28-day mortality between acute PD and intermittent hemodialysis (50% versus 49%, risk difference 0.6 [95% CI, −15.0 to 16.3]), and 28-day dialysis-free survival (42% versus 37%, risk difference 4.6 [95% CI, −11.1 to 20.3]). Mean weekly Kt/V urea was 2.11±1.14 and 2.55±1.11 in the PD and intermittent hemodialysis groups, respectively. The 7-day fluid balance of PD and intermittent hemodialysis patients was not significantly different. There was more frequent intradialytic hypotension in the intermittent hemodialysis group and more frequent hypokalemia in the PD group. CONCLUSIONS: In this study of patients with AKI, there was no significant difference in 28-day mortality between acute PD and intermittent hemodialysis.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Parapiboon W, Tatiyanupanwong S, Khositrangsikun K, et al. Lower-Dosage Acute Peritoneal Dialysis versus Acute Intermittent Hemodialysis in Acute Kidney Injury: A Randomized Controlled Trial. Clin J Am Soc Nephrol. 2024. PMID: 38809614. doi:10.2215/CJN.0000000000000482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。